Michael R Zalutsky

6PUBLICATIONS

15CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AcceleratorsNanomaterials

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 08, 2026

Synthesis and Preliminary Evaluation of the 211At-Labeled PARP Inhibitor [211At]Talazoparib as a Targeted Alpha-Particle Emitting Therapeutic.

|Oct 30, 2025

Effective treatment of human prostate carcinoma xenografts with Single-Dose PSMA-targeted [211At]YF2.

Yutian Feng, Truc T Huynh, Yongxiang Zheng

|Jun 13, 2025

Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell-Engaging Antibody in GBM via Passive and Active Mechanisms.

Yutian Feng, Benedikt Haupt, Truc T Huynh

|Jul 29, 2023

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy.

Honoka Obata, Mikako Ogawa, Michael R Zalutsky

|Nov 11, 2022

Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent.

Yutian Feng, Samantha M Sarrett, Rebecca L Meshaw

|Nov 05, 2021

Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy.

Yang Liu, Zhengyuan Zhou, Yutian Feng

Pageof 1

Frequent Collaborators

Ganesan Vaidyanathan

Tuan Vo-Dinh

Brian M Zeglis

Yutian Feng

Benedikt Haupt

Truc T Huynh

Rebecca Meshaw

Angela Martin-Regalado

1 joint publications

Aditi Thakur

1 joint publications

Joseph T Duffy

Frequent Collaborators

Ganesan Vaidyanathan

Tuan Vo-Dinh

Brian M Zeglis

Yutian Feng